Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway

Figure 4 Changes in body weights and blood glucose concentrations of Sprague-Dawley rats within 10 weeks after induction. A: Experimental flowchart: 100 diabetic rats were randomly divided into Groups A, B, C, D, and E, while 20 normal rats with no treatment were assigned to Group F; B: Changes in the body weights of Sprague-Dawley rats in each group; C: Changes in the blood glucose concentrations of Sprague-Dawley rats in each group. All results are expressed as the mean ± SD. ^aP < 0.05. ^cP < 0.001. P vs A group. FFA: Fundus fluorescein angiography; STZ: Streptozotocin.